IBDEI0IP ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8760,1,5,0)
 ;;=5^COPD
 ;;^UTILITY(U,$J,358.3,8760,2)
 ;;=^24355
 ;;^UTILITY(U,$J,358.3,8761,0)
 ;;=414.01^^35^491^23
 ;;^UTILITY(U,$J,358.3,8761,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8761,1,4,0)
 ;;=4^414.01
 ;;^UTILITY(U,$J,358.3,8761,1,5,0)
 ;;=5^Coronary Artery Disease
 ;;^UTILITY(U,$J,358.3,8761,2)
 ;;=^303281
 ;;^UTILITY(U,$J,358.3,8762,0)
 ;;=311.^^35^491^25
 ;;^UTILITY(U,$J,358.3,8762,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8762,1,4,0)
 ;;=4^311.
 ;;^UTILITY(U,$J,358.3,8762,1,5,0)
 ;;=5^Depression
 ;;^UTILITY(U,$J,358.3,8762,2)
 ;;=^35603
 ;;^UTILITY(U,$J,358.3,8763,0)
 ;;=250.01^^35^491^26
 ;;^UTILITY(U,$J,358.3,8763,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8763,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,8763,1,5,0)
 ;;=5^Diabetes, Type 1
 ;;^UTILITY(U,$J,358.3,8763,2)
 ;;=^331780
 ;;^UTILITY(U,$J,358.3,8764,0)
 ;;=250.00^^35^491^27
 ;;^UTILITY(U,$J,358.3,8764,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8764,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,8764,1,5,0)
 ;;=5^Diabetes, Type 2
 ;;^UTILITY(U,$J,358.3,8764,2)
 ;;=^331779
 ;;^UTILITY(U,$J,358.3,8765,0)
 ;;=305.90^^35^491^29
 ;;^UTILITY(U,$J,358.3,8765,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8765,1,4,0)
 ;;=4^305.90
 ;;^UTILITY(U,$J,358.3,8765,1,5,0)
 ;;=5^Drug Abuse-Unspec
 ;;^UTILITY(U,$J,358.3,8765,2)
 ;;=^268258
 ;;^UTILITY(U,$J,358.3,8766,0)
 ;;=305.93^^35^491^28
 ;;^UTILITY(U,$J,358.3,8766,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8766,1,4,0)
 ;;=4^305.93
 ;;^UTILITY(U,$J,358.3,8766,1,5,0)
 ;;=5^Drug Abuse-In Remission
 ;;^UTILITY(U,$J,358.3,8766,2)
 ;;=^268261
 ;;^UTILITY(U,$J,358.3,8767,0)
 ;;=796.2^^35^491^33
 ;;^UTILITY(U,$J,358.3,8767,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8767,1,4,0)
 ;;=4^796.2
 ;;^UTILITY(U,$J,358.3,8767,1,5,0)
 ;;=5^Elevated BP w/o HTN
 ;;^UTILITY(U,$J,358.3,8767,2)
 ;;=^273464
 ;;^UTILITY(U,$J,358.3,8768,0)
 ;;=607.84^^35^491^35
 ;;^UTILITY(U,$J,358.3,8768,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8768,1,4,0)
 ;;=4^607.84
 ;;^UTILITY(U,$J,358.3,8768,1,5,0)
 ;;=5^Erectile Dysfunction
 ;;^UTILITY(U,$J,358.3,8768,2)
 ;;=^270441
 ;;^UTILITY(U,$J,358.3,8769,0)
 ;;=530.81^^35^491^36
 ;;^UTILITY(U,$J,358.3,8769,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8769,1,4,0)
 ;;=4^530.81
 ;;^UTILITY(U,$J,358.3,8769,1,5,0)
 ;;=5^GERD
 ;;^UTILITY(U,$J,358.3,8769,2)
 ;;=^295749
 ;;^UTILITY(U,$J,358.3,8770,0)
 ;;=389.9^^35^491^39
 ;;^UTILITY(U,$J,358.3,8770,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8770,1,4,0)
 ;;=4^389.9
 ;;^UTILITY(U,$J,358.3,8770,1,5,0)
 ;;=5^Hearing Loss NOS
 ;;^UTILITY(U,$J,358.3,8770,2)
 ;;=^54552
 ;;^UTILITY(U,$J,358.3,8771,0)
 ;;=784.0^^35^491^38
 ;;^UTILITY(U,$J,358.3,8771,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8771,1,4,0)
 ;;=4^784.0
 ;;^UTILITY(U,$J,358.3,8771,1,5,0)
 ;;=5^Headaches
 ;;^UTILITY(U,$J,358.3,8771,2)
 ;;=^54133
 ;;^UTILITY(U,$J,358.3,8772,0)
 ;;=070.54^^35^491^40
 ;;^UTILITY(U,$J,358.3,8772,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8772,1,4,0)
 ;;=4^070.54
 ;;^UTILITY(U,$J,358.3,8772,1,5,0)
 ;;=5^Hepatitis C
 ;;^UTILITY(U,$J,358.3,8772,2)
 ;;=^303252
 ;;^UTILITY(U,$J,358.3,8773,0)
 ;;=272.4^^35^491^41
 ;;^UTILITY(U,$J,358.3,8773,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8773,1,4,0)
 ;;=4^272.4
 ;;^UTILITY(U,$J,358.3,8773,1,5,0)
 ;;=5^Hyperlipidemia
 ;;^UTILITY(U,$J,358.3,8773,2)
 ;;=^87281
 ;;^UTILITY(U,$J,358.3,8774,0)
 ;;=272.2^^35^491^42
 ;;^UTILITY(U,$J,358.3,8774,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8774,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,8774,1,5,0)
 ;;=5^Hyperlipidemia,Mixed
 ;;^UTILITY(U,$J,358.3,8774,2)
 ;;=^78424
 ;;
 ;;$END ROU IBDEI0IP
